Business Description
YS Biopharma Co Ltd
NAICS : 541714
SIC : 2834
ISIN : KYG9845F1090
Share Class Description:
YS: Ordinary SharesDescription
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.47 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 1 | |||||
| Debt-to-EBITDA | -2.26 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -0.45 | |||||
| Beneish M-Score | -2.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.57 | |||||
| 9-Day RSI | 49.24 | |||||
| 14-Day RSI | 52.56 | |||||
| 6-1 Month Momentum % | 54.53 | |||||
| 12-1 Month Momentum % | -59.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.41 | |||||
| Quick Ratio | 1.09 | |||||
| Cash Ratio | 0.39 | |||||
| Days Inventory | 608.72 | |||||
| Days Sales Outstanding | 296.23 | |||||
| Days Payable | 220.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -7.49 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.03 | |||||
| Operating Margin % | -50.8 | |||||
| Net Margin % | -54.84 | |||||
| FCF Margin % | -50.05 | |||||
| ROE % | -279.39 | |||||
| ROA % | -18.85 | |||||
| ROIC % | -29.43 | |||||
| ROC (Joel Greenblatt) % | -35.11 | |||||
| ROCE % | -27.78 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.93 | |||||
| PB Ratio | 0.98 | |||||
| Price-to-Tangible-Book | 1.13 | |||||
| EV-to-EBIT | -4.89 | |||||
| EV-to-EBITDA | -5.7 | |||||
| EV-to-Revenue | 2.42 | |||||
| EV-to-Forward-Revenue | 1.75 | |||||
| EV-to-FCF | -4.83 | |||||
| Earnings Yield (Greenblatt) % | -20.45 | |||||
| FCF Yield % | -26.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:YS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
YS Biopharma Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 79.167 | ||
| EPS (TTM) ($) | -0.569 | ||
| Beta | 0 | ||
| Volatility % | 122.81 | ||
| 14-Day RSI | 52.56 | ||
| 14-Day ATR ($) | 0.098527 | ||
| 20-Day SMA ($) | 0.83341 | ||
| 12-1 Month Momentum % | -59.87 | ||
| 52-Week Range ($) | 0.3503 - 1.97 | ||
| Shares Outstanding (Mil) | 188.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
YS Biopharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
YS Biopharma Co Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
YS Biopharma Co Ltd Frequently Asked Questions
What is YS Biopharma Co Ltd(YS)'s stock price today?
The current price of YS is $0.80. The 52 week high of YS is $1.97 and 52 week low is $0.35.
When is next earnings date of YS Biopharma Co Ltd(YS)?
The next earnings date of YS Biopharma Co Ltd(YS) is 2024-08-15 Est..
Does YS Biopharma Co Ltd(YS) pay dividends? If so, how much?
YS Biopharma Co Ltd(YS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers